With Vertex Pharmaceuticals cystic fibrosis announcement Corbus could be a good short. Unless they can show a lung function improvement, why bother doing a phase 3.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.